Pages that link to "Q28334619"
Jump to navigation
Jump to search
The following pages link to Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells (Q28334619):
Displaying 33 items.
- Pathogenesis of human immunodeficiency virus infection (Q24634681) (← links)
- Classification Framework and Chemical Biology of Tetracycline-Structure-Based Drugs (Q27024054) (← links)
- RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells (Q28610868) (← links)
- Novel paradigms for drug discovery: computational multitarget screening (Q30662767) (← links)
- Monoclonal antibody against Mycoplasma fermentans-specific aminoglycoglycerolipid (Q30938673) (← links)
- Ultrastructural pathology of human immunodeficiency virus infection (Q33209535) (← links)
- Scientific surveillance and the control of AIDS: a call for open debate (Q33556606) (← links)
- Differential protein expression and surface presentation generate high-frequency antigenic variation in Mycoplasma fermentans (Q33616724) (← links)
- Mycoplasma penetrans and other mycoplasmas in urine of human immunodeficiency virus-positive children. (Q33960321) (← links)
- Oxidative stress, HIV and AIDS (Q33985505) (← links)
- Is a positive western blot proof of HIV infection? (Q34058940) (← links)
- Use of minocycline in viral infections (Q35062807) (← links)
- Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines (Q36954935) (← links)
- Isolation of Mycoplasma species from bronchoalveolar lavages of patients positive and negative for human immunodeficiency virus (Q37086770) (← links)
- Is Minocycline an Antiviral Agent? A Review of Current Literature (Q38547631) (← links)
- Fluorometric quantitation of broth-cultured mycoplasmas by using alkaline ethidium bromide (Q40175018) (← links)
- Links and interactions between mycoplasmas and viruses: past confusions and present realities (Q40441243) (← links)
- The epidemiology and transmission of AIDS: a hypothesis linking behavioural and biological determinants to time, person and place (Q40522014) (← links)
- A critical analysis of the HIV-T4-cell-AIDS hypothesis (Q40522019) (← links)
- Murine AIDS: a model for the human disease or a distinct entity? (Q40615984) (← links)
- Induction of tumor necrosis factor alpha (TNF alpha) and enhancement of HIV-1 replication in the J22HL60 cell line by Mycoplasma penetrans (Q41243417) (← links)
- Suppression of HIV-1 reverse transcriptase activity by culture supernatants of mycoplasmas (Q41384766) (← links)
- The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapy (Q41394569) (← links)
- Identification of phosphocholine-containing glycoglycerolipids purified from Mycoplasma fermentans-infected human helper T-cell culture as components of M. fermentans (Q41402570) (← links)
- Mycoplasma stimulates HIV-1 expression from acutely- and dormantly-infected promonocyte/monoblastoid cell lines (Q41504213) (← links)
- Fusion ofMycoplasma fermentansstrain incognitus with T‐lymphocytes (Q41620705) (← links)
- Homologies between mycoplasma adhesion peptide, CD4 and class II MHC proteins: a possible mechanism for HIV-mycoplasma synergism in AIDS (Q42040848) (← links)
- Linkage and independence of AIDS and Kaposi disease: the interaction of human immunodeficiency virus and some coagents (Q45852670) (← links)
- Micacocidin A, B and C, novel antimycoplasma agents from Pseudomonas sp. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. (Q48769692) (← links)
- No evidence of mycoplasmas in peripheral blood mononuclear cell fraction of HIV-infected patients (Q72721136) (← links)
- Structure of a novel phosphocholine-containing aminoglycoglycerolipid of Mycoplasma fermentans (Q74012738) (← links)
- Drug repurposing for new, efficient, broad spectrum antivirals (Q91834255) (← links)
- A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials (Q94957046) (← links)